RETNLB Antibody - Cat. #: CSB-PA824653

SKU: CSB-PA824653

Size :50ul

Clone Number:

Aliases:C/EBP epsilon regulated myeloid specific secreted cysteine rich protein precursor 2 antibody; CCGR antibody; Colon and small intestine specific cysteine rich protein antibody; Colon and small intestine-specific cysteine-rich protein antibody; Colon carcinoma related gene protein antibody; Colon carcinoma-related gene protein antibody; Cysteine rich secreted A12 alpha like protein 1 antibody; Cysteine rich secreted protein A12 alpha like 1 antibody; Cysteine rich secreted protein FIZZ2 antibody; Cysteine-rich secreted protein A12-alpha-like 1 antibody; Cysteine-rich secreted protein FIZZ2 antibody; FIZZ1 antibody; FIZZ2 antibody; Found in inflammatory zone 1 antibody; HXCP2 antibody; RELM beta antibody; RELMb antibody; RELMbeta antibody; Resistin like beta antibody; Resistin like protein beta antibody; Resistin-like beta antibody; RETNB_HUMAN antibody; RETNL2 antibody; Retnlb antibody; XCP2 antibody

Product Type:Polyclonal Antibody

Immunogen Species:Homo sapiens (Human)

UniProt ID:Q9BQ08

Immunogen:Fusion protein of Human RETNLB

Raised in:Rabbit

Species Reactivity:Human

Tested Applications:ELISA, IHC; ELISA:1:2000-1:5000, IHC:1:50-1:200

Background:Resistin-like beta is a protein that in humans is encoded by the RETNLB gene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.

Clonality:Polyclonal

Isotype:IgG

Purification Method:Antigen affinity purification

Conjugate:Non-conjugated

Buffer:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol

Form:Liquid

Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names:RETNLB

Research Areas:Cancer;Signal transduction